In addition, a biomarker panel combining NfL serum levels and MRI markers (i.e., the volume of infarction and WMHs) was found to be able to improve the predictive value and facilitate precise ischemic stroke treatments for patients [52]. The gene discussed is NEFL; the disease is infarction.